隆華科技(300263.SZ):擬1.99億元收購科博思匯智持有的科博思33.28%股權
格隆匯 6 月 23日丨隆華科技(300263.SZ)公佈,2020年6月23日,公司與科博思匯智簽訂了《關於收購洛陽科博思新材料科技有限公司剩餘股權的補充協議》,根據公司2018年收購科博思股權時簽訂的《股權轉讓及增資協議》中未來股權收購安排,公司擬收購科博思匯智持有的科博思33.28%股權並根據科博思業績承諾完成情況分期支付其股權收購款,交易完成後公司將持有科博思76.81%股權,擬交易對價為1.99億元,具體金額根據科博思業績承諾完成情況確定。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.